Jeonjinbio Co., Ltd. (KOSDAQ:110020)
2,060.00
+20.00 (0.98%)
At close: Oct 21, 2026
Jeonjinbio Revenue
Jeonjinbio had revenue of 2.94B KRW in the quarter ending June 30, 2026, a decrease of -19.39%. This brings the company's total for the last twelve months to 13.71B, down -11.24% year-over-year. In the year 2025, Jeonjinbio had annual revenue of 13.69B, down -28.94%. That makes Jeonjinbio the 37,226th largest company in the world by revenue and 2,372nd in South Korea.
Revenue (ttm)
13.71B
Revenue Growth
-11.24%
P/S Ratio
1.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
18.66B
Revenue by Segment
Fiscal year ended Dec 31, 2024 See the full Jeonjinbio breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.69B | -5.58B | -28.94% |
| Dec 31, 2024 | 19.27B | 3.59B | 22.91% |
| Dec 31, 2023 | 15.68B | 7.89B | 101.18% |
| Dec 31, 2022 | 7.79B | 4.58B | 142.48% |
| Dec 31, 2021 | 3.21B | -652.23M | -16.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Mcnulty Korea | 97.26B |
| Softcen | 59.63B |
| WooGene B&G | 56.49B |
| U.I.Display | 52.36B |
| VC Inc. | 52.30B |
| Sewha P&C INC. | 37.65B |
| Ubion Co.Ltd. | 33.56B |
| RootK | 30.84B |